Global Luciferase Assay Kits Market, By Application (Cell Signaling Pathways, Promoter Structural and Functional Analysis, Gene Regulation, Protein Interaction), Component (D-Luciferin, 5X Firefly Luciferase Lysis Buffer, Firefly Luciferase Assay Buffer (Lyophilized)), End User (Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROS), Hospital and Diagnostic Laboratories) – Industry Trends and Forecast to 2029
Market Analysis and Size
Reporter gene assays are one of the most widely used cell-based assays for elucidating the biological role of target molecules. As a result, fluorescence assays are preferred by researchers for real-time analysis of dynamic processes occurring in living cells. This is due to the availability of different coloured reporter gene variants, as well as the fact that cell lysis or the addition of any kind of substrate is not required for quantification.
-
Data Bridge Market Research analyses that the luciferase assay kits market is expected to grow at a CAGR of 8.74% during the forecast period. Luciferase assay kits market is growing due to factor such as increasing preferences for cell based assays.
Market Definition
A luciferase assay is used to determine whether a protein can activate or suppress the expression of a specific gene. Unlike ChIP or EMSA assays, which only evaluate a protein's ability to interact with a region of DNA, a luciferase assay can establish a functional link between the presence of the protein and the amount of gene product produced. This assay cannot determine whether the protein directly interacts with DNA; the protein may affect transcription indirectly by activating or repressing a separate protein or protein complex that affects transcription.
Luciferase Assay Kits Market Dynamics
Drivers
-
The rise in the adoption of luciferase assay kits from various end use industry
The luciferase assay is used to detect and test ATP, which is expected to drive the growth of the luciferase assay market. The luciferase assay market will be driven by increasing technological advancements for quantitative visualisation of gene expression using a camera. Researchers use luciferase assays in bioluminescence assays to find ATP and measure light emitted during metabolic activity. Food and beverage companies use it to check for microbial contamination, which is expected to drive growth. The luciferase assay is also useful in detecting gene expression at various stages of growth in transgenic organisms, which is increasing their growth. Increasing applications for luciferase assays, such as determining cell functions such as cell fate, differentiation, and growth, are driving the luciferase assay market growth.
The increase in the cost of operations and the decline in reimbursements for laboratory services
The repeated use of luciferase assays in gene expression research, as well as gene transcription and translation levels, is influencing growth. The cost advantage of manufacturing and the rise in per capita income are driving the growth of luciferase assays.
Opportunities
The growth of emerging countries and the increasing demand for personalised medicines will create new opportunities for market growth during the forecast period.
Restraints/Challenges
On the other hand, the rising cost of cell biology research will act as a restraint on the growth of the luciferase assay kits market during the forecast period.
This Luciferase Assay Kits market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Luciferase Assay Kits market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Covid-19 Impact on Luciferase Assay Kits Market
Pharmaceutical and biotech companies, in collaboration with governments around the world, are working to address the COVID-19 outbreak, from vaccine development to planning for medicine supply chain challenges. Approximately 115 vaccine candidates and 155 molecules are currently in the RandD pipeline. Furthermore, commonly used drugs such as hydroxychloroquine have seen a dramatic increase in demand for the treatment of COVID-19. Due to the high demand for these drugs, manufacturers of COVID-19 management drugs have a huge opportunity, as many developed countries are running low on these drugs. The pharmaceutical and biotechnology industries are expected to grow significantly in the future due to the demand for COVID-19 vaccines and treatment drugs.
Recent Development
-
Pfizer, Inc. invested USD 500 million in August 2019 to expand its gene therapy manufacturing plant in Sanford, California. This initiative enabled the company to improve the production of highly specialised medicines used to treat genetic disorders.
For example,
- in 2019, a group of Chinese hospitals and universities collaborated to develop a novel androgen receptor-mediated reporter gene assay to study the anti/androgenic activities of porcine aortic endothelial cells (PAE).
Global Luciferase Assay Kits Market Scope
The Luciferase Assay Kits market is segmented on the basis of application, component and end user.. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Application
- Cell Signaling Pathways
- Promoter Structural
- Functional Analysis
- Gene Regulation
- Protein Interaction
Based on application, luciferase assay kits market is segmented into cell signaling pathways, promoter structural and functional analysis, gene regulation and protein interaction.
Component
- D-luciferin
- 5x firefly luciferase lysis buffer
- firefly luciferase assay buffer (lyophilized)
Based on component, luciferase assay kits market is segmented into d-luciferin, 5 x firefly luciferase lysis buffers and firefly luciferase assay buffer (lyophilized).
End User
- Academic And Research Institutes
- Pharmaceutical And Biotechnology Companies
- Contract Research Organizations (CROs)
- Hospital And Diagnostic Laboratories
Luciferase assay kits market has also been segmented on the basis of end user into academic and research institutes, pharmaceutical and biotechnology companies, contract research organizations (CROS) and hospital and diagnostic laboratories.
Luciferase Assay Kits Market Regional Analysis/Insights
The Luciferase Assay Kits market is analysed and market size insights and trends are provided by country, application, component and end user as referenced above.
The countries covered in the Luciferase Assay Kits market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
The Asia-Pacific region dominates the luciferase assay kits market due to the majority of players, as well as the growth of the healthcare industry and rising per capita income in this region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The Luciferase Assay Kits market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for Luciferase Assay Kits market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the Luciferase Assay Kits market. The data is available for historic period 2010-2020.
Competitive Landscape and Luciferase Assay Kits Market Share Analysis
The Luciferase Assay Kits market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to Luciferase Assay Kits market.
Some of the major players operating in the Luciferase Assay Kits market are Merck KGaA, Thermo Fisher Scientific Inc., Promega Corporation, PerkinElmer Inc., Biotium, Abcam plc, Bio-Rad Laboratories, Inc., BD., Geno Technology Inc., GeneCopoeia, Inc., InvivoGen, PromoCell GmbH, OZ Biosciences, Novus Biologicals, New England Biolabs, Takara Bio Inc., www.elabscience.com, Cell Technology., AAT Bioquest, Inc., Molecular Devices, LLC, Active Motif, Inc., among others.
SKU-